키토산 시장 : 공급원별, 용도별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Chitosan Market By Source (Shrimp, Squid, Crab, Krill, Others) , By Application (Water treatment, Biomedical and Pharmaceutical, Cosmetics, Food and Beverage, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,248,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,465,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

키토산 시장의 2023년 시장 규모는 78억 달러로 2024-2033년 CAGR 18.7%로 2033년에는 428억 달러에 달할 것으로 예상됩니다.

키토산은 랍스터, 새우, 게 등 조개류의 외골격에서 합성되는 천연 바이오폴리머입니다. 이 바이오폴리머는 탈아세틸화 과정을 통해 키틴에서 키토산으로 전환됩니다. 키토산은 생체 적합성, 생분해성, 항균성, 항산화성 등 다양한 특성을 가지고 있어 영양 보충제, 식품 포장, 상처 치료 등 다양한 응용 분야에 적용될 수 있습니다.

세계 키토산 시장의 성장은 의료, 제약, 식음료, 농업 등 다양한 산업에서 키토산 수요가 급증한 것이 주요 요인으로 작용하고 있습니다. 키토산은 무독성이며 인체 조직에 잘 적응하기 때문에 상처 드레싱, 약물전달 시스템, 조직 공학 등 의료용 제약 응용 분야에 적합합니다. 항균성, 생체적합성, 수분 보유력은 상처 치유와 피부 관리에 도움이 됩니다. 예를 들어, 유럽질병예방통제센터(ECDC)의 2018년 추정에 따르면, 항생제 내성균 감염으로 매년 약 3만 3,000명이 사망하고 있습니다. 이에 따라 천연 및 합성 분자로부터 새로운 항균제를 개발할 필요성이 대두되고 있으며, 이는 의료 부문에서 키토산의 수요를 촉진하고 있습니다. 또한, 키토산은 중금속 및 염료와 같은 오염 물질과 결합하는 능력을 보여주기 때문에 수처리를 위한 지속가능한 선택이 되고 있습니다. 또한, 세계 인구 증가에 따라 세계 식량 수요가 증가함에 따라 지속가능한 농업의 필요성이 크게 증가하고 있습니다. 키토산은 기존 농약을 대체할 수 있는 지속가능한 대안으로 작용하여 보다 안전한 농법 채택을 촉진할 수 있습니다. 이는 키토산 기반 제제가 해충과 질병을 효과적으로 퇴치하고 화학 농약의 필요성을 줄이며 작물 수확량을 증가시켜 농업 부문의 수요를 증가시킨다는 사실에 기인합니다.

일부 연구에서는 키토산이 지방과 콜레스테롤을 체내로 흡수하는 대신 체외로 배출시켜 체중 감소를 돕고 콜레스테롤 수치를 낮춘다고 주장하기도 합니다. 그러나 현재의 연구는 이 주장을 지지하지 않으며, 2,000년대 초에 실시된 임상시험에서는 키토산이 대변의 지방 배설을 촉진하지 않으며 지방을 포획하는 징후도 없는 것으로 나타났습니다. 따라서 이러한 모순은 키토산 보충제에 대한 수요를 방해하고 세계 시장의 성장을 크게 저해하고 있습니다. 키토산의 높은 생산 비용도 세계 시장의 주요 억제요인으로 작용하고 있습니다. 반면, 키토산의 항균 특성으로 인해 식품의 유통기한을 연장하는 천연 방부제로서의 수요가 급증하고 있습니다. 따라서 제조업체들은 식품의 부패를 방지하기 위해 키토산을 기반으로 한 식용 필름 및 코팅제 개발에 주력하고 있으며, 이는 예측 기간 동안 시장 성장에 유익한 기회를 제공할 것으로 예상됩니다.

키토산 시장은 공급원, 용도, 지역으로 구분됩니다. 공급원별로 시장은 새우, 오징어, 게, 크릴, 기타로 분류됩니다. 용도별로는 수처리, 생물의료 및 의약품, 화장품, 식음료, 기타로 나뉩니다. 지역별로 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

주요 조사 결과

공급원별로는 새우 부문이 2023년 가장 높은 시장 점유율을 차지했으며, 2033년에도 우위를 유지할 것으로 보입니다.

용도별로는 수처리 부문이 2023년 주요 주주였으며, 예측 기간 동안 이러한 추세는 계속될 것으로 보입니다.

지역별로는 아시아태평양이 예측 기간 동안 가장 빠른 성장세를 보일 것으로 예상됩니다.

본 보고서에서 가능한 커스터마이징(추가 비용 및 일정이 있습니다.)

• 제품에 포함된 원재료 분석(% 단위)
• 제조 능력
• 제품 벤치마크/제품 사양 및 용도
• 제품 수명주기
• 공급망 분석과 공급업체 마진
• 지역별 신규 진입 기업
• 평균 소비지출
• 시장 진입 전략
• 제품/부문별 시장 세분화
• 주요 제조업체의 신제품 개발/제품 매트릭스
• 통증 포인트 분석
• 규제 가이드라인
• 전략적 제안
• 고객의 관심사에 특화된 추가 기업 개요
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 예측
• 평균 판매 가격 분석/가격 포인트 분석
• 기업 개요 확대 목록
• 과거 시장 데이터
• 수출입 분석/데이터
• 주요 진입기업 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 포함, 엑셀 형식)
• 고객/소비자/원료 공급업체 목록 - 가치사슬 분석
• 세계/지역/국가별 시장 점유율 분석
• 1인당 소비 동향
• SWOT 분석
• 수량 시장 규모 및 예측

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 키토산 시장 : 공급원별

• 시장 개요
• 새우
• 오징어
• 게
• 크릴
• 기타

제5장 키토산 시장 : 용도별

• 시장 개요
• 수처리
• 의료 의약품
• 화장품
• 식품 및 음료
• 기타

제6장 키토산 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 키토산 시장
  • 캐나다의 키토산 시장
  • 멕시코의 키토산 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스의 키토산 시장
  • 독일의 키토산 시장
  • 이탈리아의 키토산 시장
  • 스페인의 키토산 시장
  • 영국의 키토산 시장
  • 기타 유럽의 키토산 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국의 키토산 시장
  • 일본의 키토산 시장
  • 인도의 키토산 시장
  • 한국의 키토산 시장
  • 호주의 키토산 시장
  • 기타 아시아태평양의 키토산 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 키토산 시장
  • 남아프리카공화국의 키토산 시장
  • 사우디아라비아의 키토산 시장
  • 기타 라틴아메리카, 중동 및 아프리카 키토산 시장

제7장 경쟁 상황

• 소개
• 주요 성공 전략
• 주요 기업 10개사 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제8장 기업 개요

• PRIMEX EHF
• ADVANCED BIOPOLYMERS AS
• Panvo Organics Pvt Ltd.
• Heppe Medical Chitosan GmbH
• G.T.C. Bio Corporation
• Kitozyme S.A.
• Novamatrix
• Agratech International, Inc.
• Golden-Shell Pharmaceutical Co. Ltd.
• Qingdao Yunzhou Biochemistry Co. Ltd.

ksm

영문 목차

영문목차

The chitosan market was valued at $7.8 billion in 2023, and is projected to reach $42.8 billion by 2033, growing at a CAGR of 18.7% from 2024 to 2033.

Chitosan is a natural biopolymer that is synthesized in the outer skeleton of shellfish such as lobster, shrimp, and crab. This biopolymer is derived from chitin through a process of deacetylation, which converts it into chitosan. It exhibits a myriad of properties such as biocompatibility, biodegradability, antimicrobial activity, and antioxidant properties, which make suitable for use in a wide range of applications; for instance, it used in dietary supplements, food packaging, and in wound care.

The growth of the global chitosan market is majorly driven by surge in demand for chitosan from various industries, including healthcare, pharmaceuticals, food & beverages, and agriculture. Chitosan is non-toxic and compatible with human tissues, making it suitable for medical and pharmaceutical applications, including wound dressings, drug delivery systems, and tissue engineering. Its antimicrobial, biocompatible, and water retention properties aid in wound healing and skin care. For instance, according to the 2018 estimates of the European Centre for Disease Prevention and Control (ECDC), nearly 33,000 individuals die every year due to infection with antibiotic-resistant bacteria. This has necessitated the development of developing new antimicrobials from natural and synthetic molecules, which, in turn, has fostered the demand for chitosan in the medical sector. In addition, chitosan's exhibits the ability to bind with contaminants, including heavy metals and dyes, which makes it a sustainable choice for water treatment. In addition, as the world's food demand is aligning with the increasing global population, the need for sustainable agricultural practices has increased notably. Chitosan serves as a sustainable alternative to conventional agrochemicals, thus fostering the adoption of safer agricultural practices. This is attributed to the fact that chitosan-based formulations can effectively control pests and diseases, reduce the need for chemical pesticides, and improve crop yields, which boosts its demand in the agricultural sector.

Some studies claim that chitosan assists in weight loss and lowers cholesterol levels by eliminating fat and cholesterol from the body instead of allowing the body to absorb them. However, current studies do not support this claim. Clinical trials conducted in the early 2000s found that chitosan did not facilitate fat excretion in stool, and there is no indication that it traps fat. Thus, such discrepancies hamper the demand for chitosan supplements, which significantly hampers the growth of the global market. High production costs of chitosan further acts as a key deterrent factor of the global market. Contrarily, surge in demand for chitosan as a natural preservative to extend the shelf life of food products due to its antimicrobial properties. Thus, manufacturers are focusing on the development of edible chitosan-based edible films and coatings to prevent the spoilage of food products, which is expected to offer remunerative opportunities for the growth of the market during the forecast period.

The chitosan market is segmented into source, application, and region. By source, the market is classified into shrimp, squid, crab, krill, and others. On the basis of application, it is divided into water treatment, biomedical & pharmaceutical, cosmetics, food & beverage, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By source, the shrimp segment held the highest market share in 2023 and is likely to retain its dominance by 2033.

Depending on application, the water treatment segment was the major shareholder in 2023 and is expected to continue the same trend during the forecast period.

Region wise, Asia-Pacific is expected to experience the fastest growth during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global chitosan market include PRIMEX EHF, ADVANCED BIOPOLYMERS AS, Panvo Organics Pvt Ltd., Heppe Medical Chitosan GmbH, G.T.C. Bio Corporation, Kitozyme S.A., Novamatrix, Agratech International, Inc., Golden-Shell Pharmaceutical Co. Ltd., and Qingdao Yunzhou Biochemistry Co. Ltd. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Analysis of raw material in a product (by %)
• Manufacturing Capacity
• Product Benchmarking / Product specification and applications
• Product Life Cycles
• Supply Chain Analysis & Vendor Margins
• Upcoming/New Entrant by Regions
• Average Consumer Expenditure
• Go To Market Strategy
• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Pain Point Analysis
• Regulatory Guidelines
• Strategic Recommendations
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Average Selling Price Analysis / Price Point Analysis
• Expanded list for Company Profiles
• Historic market data
• Import Export Analysis/Data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• List of customers/consumers/raw material suppliers- value chain analysis
• Market share analysis of players at global/region/country level
• Per Capita Consumption Trends
• SWOT Analysis
• Volume Market Size and Forecast

Key Market Segments

By Source

• Shrimp
• Squid
• Crab
• Krill
• Others

By Application

• Water treatment
• Biomedical and Pharmaceutical
• Cosmetics
• Food and Beverage
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• PRIMEX EHF
• ADVANCED BIOPOLYMERS AS
• Panvo Organics Pvt Ltd.
• Heppe Medical Chitosan GmbH
• G.T.C. Bio Corporation
• Kitozyme S.A.
• Novamatrix
• Agratech International, Inc.
• Golden-Shell Pharmaceutical Co. Ltd.
• Qingdao Yunzhou Biochemistry Co. Ltd.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: CHITOSAN MARKET, BY SOURCE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Source
• 4.2. Shrimp
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Squid
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Crab
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country
• 4.5. Krill
  • 4.5.1. Key Market Trends, Growth Factors and Opportunities
  • 4.5.2. Market Size and Forecast, By Region
  • 4.5.3. Market Share Analysis, By Country
• 4.6. Others
  • 4.6.1. Key Market Trends, Growth Factors and Opportunities
  • 4.6.2. Market Size and Forecast, By Region
  • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: CHITOSAN MARKET, BY APPLICATION

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Application
• 5.2. Water Treatment
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Biomedical And Pharmaceutical
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Cosmetics
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Food And Beverage
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country
• 5.6. Others
  • 5.6.1. Key Market Trends, Growth Factors and Opportunities
  • 5.6.2. Market Size and Forecast, By Region
  • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: CHITOSAN MARKET, BY REGION

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By Region
• 6.2. North America
  • 6.2.1. Key Market Trends and Opportunities
  • 6.2.2. Market Size and Forecast, By Source
  • 6.2.3. Market Size and Forecast, By Application
  • 6.2.4. Market Size and Forecast, By Country
  • 6.2.5. U.S. Chitosan Market
    • 6.2.5.1. Market Size and Forecast, By Source
    • 6.2.5.2. Market Size and Forecast, By Application
  • 6.2.6. Canada Chitosan Market
    • 6.2.6.1. Market Size and Forecast, By Source
    • 6.2.6.2. Market Size and Forecast, By Application
  • 6.2.7. Mexico Chitosan Market
    • 6.2.7.1. Market Size and Forecast, By Source
    • 6.2.7.2. Market Size and Forecast, By Application
• 6.3. Europe
  • 6.3.1. Key Market Trends and Opportunities
  • 6.3.2. Market Size and Forecast, By Source
  • 6.3.3. Market Size and Forecast, By Application
  • 6.3.4. Market Size and Forecast, By Country
  • 6.3.5. France Chitosan Market
    • 6.3.5.1. Market Size and Forecast, By Source
    • 6.3.5.2. Market Size and Forecast, By Application
  • 6.3.6. Germany Chitosan Market
    • 6.3.6.1. Market Size and Forecast, By Source
    • 6.3.6.2. Market Size and Forecast, By Application
  • 6.3.7. Italy Chitosan Market
    • 6.3.7.1. Market Size and Forecast, By Source
    • 6.3.7.2. Market Size and Forecast, By Application
  • 6.3.8. Spain Chitosan Market
    • 6.3.8.1. Market Size and Forecast, By Source
    • 6.3.8.2. Market Size and Forecast, By Application
  • 6.3.9. UK Chitosan Market
    • 6.3.9.1. Market Size and Forecast, By Source
    • 6.3.9.2. Market Size and Forecast, By Application
  • 6.3.10. Rest of Europe Chitosan Market
    • 6.3.10.1. Market Size and Forecast, By Source
    • 6.3.10.2. Market Size and Forecast, By Application
• 6.4. Asia-Pacific
  • 6.4.1. Key Market Trends and Opportunities
  • 6.4.2. Market Size and Forecast, By Source
  • 6.4.3. Market Size and Forecast, By Application
  • 6.4.4. Market Size and Forecast, By Country
  • 6.4.5. China Chitosan Market
    • 6.4.5.1. Market Size and Forecast, By Source
    • 6.4.5.2. Market Size and Forecast, By Application
  • 6.4.6. Japan Chitosan Market
    • 6.4.6.1. Market Size and Forecast, By Source
    • 6.4.6.2. Market Size and Forecast, By Application
  • 6.4.7. India Chitosan Market
    • 6.4.7.1. Market Size and Forecast, By Source
    • 6.4.7.2. Market Size and Forecast, By Application
  • 6.4.8. South Korea Chitosan Market
    • 6.4.8.1. Market Size and Forecast, By Source
    • 6.4.8.2. Market Size and Forecast, By Application
  • 6.4.9. Australia Chitosan Market
    • 6.4.9.1. Market Size and Forecast, By Source
    • 6.4.9.2. Market Size and Forecast, By Application
  • 6.4.10. Rest of Asia-Pacific Chitosan Market
    • 6.4.10.1. Market Size and Forecast, By Source
    • 6.4.10.2. Market Size and Forecast, By Application
• 6.5. LAMEA
  • 6.5.1. Key Market Trends and Opportunities
  • 6.5.2. Market Size and Forecast, By Source
  • 6.5.3. Market Size and Forecast, By Application
  • 6.5.4. Market Size and Forecast, By Country
  • 6.5.5. Brazil Chitosan Market
    • 6.5.5.1. Market Size and Forecast, By Source
    • 6.5.5.2. Market Size and Forecast, By Application
  • 6.5.6. South Africa Chitosan Market
    • 6.5.6.1. Market Size and Forecast, By Source
    • 6.5.6.2. Market Size and Forecast, By Application
  • 6.5.7. Saudi Arabia Chitosan Market
    • 6.5.7.1. Market Size and Forecast, By Source
    • 6.5.7.2. Market Size and Forecast, By Application
  • 6.5.8. Rest of LAMEA Chitosan Market
    • 6.5.8.1. Market Size and Forecast, By Source
    • 6.5.8.2. Market Size and Forecast, By Application

CHAPTER 7: COMPETITIVE LANDSCAPE

• 7.1. Introduction
• 7.2. Top Winning Strategies
• 7.3. Product Mapping of Top 10 Player
• 7.4. Competitive Dashboard
• 7.5. Competitive Heatmap
• 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

• 8.1. PRIMEX EHF
  • 8.1.1. Company Overview
  • 8.1.2. Key Executives
  • 8.1.3. Company Snapshot
  • 8.1.4. Operating Business Segments
  • 8.1.5. Product Portfolio
  • 8.1.6. Business Performance
  • 8.1.7. Key Strategic Moves and Developments
• 8.2. ADVANCED BIOPOLYMERS AS
  • 8.2.1. Company Overview
  • 8.2.2. Key Executives
  • 8.2.3. Company Snapshot
  • 8.2.4. Operating Business Segments
  • 8.2.5. Product Portfolio
  • 8.2.6. Business Performance
  • 8.2.7. Key Strategic Moves and Developments
• 8.3. Panvo Organics Pvt Ltd.
  • 8.3.1. Company Overview
  • 8.3.2. Key Executives
  • 8.3.3. Company Snapshot
  • 8.3.4. Operating Business Segments
  • 8.3.5. Product Portfolio
  • 8.3.6. Business Performance
  • 8.3.7. Key Strategic Moves and Developments
• 8.4. Heppe Medical Chitosan GmbH
  • 8.4.1. Company Overview
  • 8.4.2. Key Executives
  • 8.4.3. Company Snapshot
  • 8.4.4. Operating Business Segments
  • 8.4.5. Product Portfolio
  • 8.4.6. Business Performance
  • 8.4.7. Key Strategic Moves and Developments
• 8.5. G.T.C. Bio Corporation
  • 8.5.1. Company Overview
  • 8.5.2. Key Executives
  • 8.5.3. Company Snapshot
  • 8.5.4. Operating Business Segments
  • 8.5.5. Product Portfolio
  • 8.5.6. Business Performance
  • 8.5.7. Key Strategic Moves and Developments
• 8.6. Kitozyme S.A.
  • 8.6.1. Company Overview
  • 8.6.2. Key Executives
  • 8.6.3. Company Snapshot
  • 8.6.4. Operating Business Segments
  • 8.6.5. Product Portfolio
  • 8.6.6. Business Performance
  • 8.6.7. Key Strategic Moves and Developments
• 8.7. Novamatrix
  • 8.7.1. Company Overview
  • 8.7.2. Key Executives
  • 8.7.3. Company Snapshot
  • 8.7.4. Operating Business Segments
  • 8.7.5. Product Portfolio
  • 8.7.6. Business Performance
  • 8.7.7. Key Strategic Moves and Developments
• 8.8. Agratech International, Inc.
  • 8.8.1. Company Overview
  • 8.8.2. Key Executives
  • 8.8.3. Company Snapshot
  • 8.8.4. Operating Business Segments
  • 8.8.5. Product Portfolio
  • 8.8.6. Business Performance
  • 8.8.7. Key Strategic Moves and Developments
• 8.9. Golden-Shell Pharmaceutical Co. Ltd.
  • 8.9.1. Company Overview
  • 8.9.2. Key Executives
  • 8.9.3. Company Snapshot
  • 8.9.4. Operating Business Segments
  • 8.9.5. Product Portfolio
  • 8.9.6. Business Performance
  • 8.9.7. Key Strategic Moves and Developments
• 8.10. Qingdao Yunzhou Biochemistry Co. Ltd.
  • 8.10.1. Company Overview
  • 8.10.2. Key Executives
  • 8.10.3. Company Snapshot
  • 8.10.4. Operating Business Segments
  • 8.10.5. Product Portfolio
  • 8.10.6. Business Performance
  • 8.10.7. Key Strategic Moves and Developments

관련자료